MENU
OCGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Ocugen (OCGN) Ownership - Who owns Ocugen?
Profile
Industry
N/A
Address
11 Great Valley Parkway
Phone
+1 484 328-4701
Employees
84
Web
https://www.ocugen.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
225.57M
P/E Ratio
N/A
Total Cash
38.7M
Projected Growth
N/A
Total Debt
6.78M
Revenue
4.7M
Risk (Beta)
2.36
Dividend Yield
N/A
Total Cash/Share
0.13
Total Debt/Equity
N/A
Revenue/Share
0.02 USD as % of share price
Fundamentals
OCGN
Capitalization
226M
P/E Ratio
N/A
Risk (Beta)
2.36
Dividend Yield
N/A
Total Cash
38.7M
Total Cash/Share
0.13
Total Debt
6.78M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.02%
Revenue
4.7M
ROE
N/A
Book Value
40.6M
P/B Ratio
5.55
Cash Flow
N/A
Earnings
-0.19
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.9M
Current Ratio
2.58
Current Revenue Per Employee
13583.33
Dividends Per Share - Security
N/A
EBITDA
-50.89M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-74.87
Shares Held By Institutions
142M
Shares Outstanding - Current
291M
Total Liabilities
21.3M
Total Volume MTD
N/A
Value
N/A
Gain YTD
34.661
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in the development and commercialization of therapies for eye diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
11 Great Valley Parkway
Phone
+1 484 328-4701
Employees
84
Web
https://www.ocugen.com